Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial | MicrobiomeTrials← Back to trialsNCT07060638
Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-01-27Est. Completion: 2029-06
Enrollment target: 216 participants Locations- Indiana University, Indianapolis, Indiana, United States
- University of Louisville, Louisville, Kentucky, United States
- Mayo Clinic, Rochester, Minnesota, United States
- Cleveland Clinic, Cleveland, Ohio, United States
- University of Texas Southwestern Medical School, Dallas, Texas, United States
- Virginia Commonwealth University, Richmond, Virginia, United States
Other microbiome trials you might be interested in
Alcoholic Liver Disease (ALD)Alcohol Use Disorder
Harmful alcohol use is a common cause of hospital admissions and the leading cause of liver cirrhosis. Timely detection …
Bergen, NorwayEst. completion May 15, 2030
Type 2 Diabetes Mellitus (T2DM)MASH - Metabolic Dysfunction-Associated SteatohepatitisMetabolic Dysfunction-associated Fatty Liver Disease
This observational study aims to evaluate a new diagnostic tool, the Liver Inflammation Index, in detecting Metabolic Dy…
Bengbu, ChinaEst. completion Dec 31, 2027